speb/financial-data huggingface dataset:
Financial ratios for JMGI.L — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: 1747154794.520548
Buffett classification: The Gruesome
Stock price: 0.015205479452054796
Shares outstanding: 942220167
Book value: 1747154794.520548
P/B ratio: 0.00820013740829513
Market cap (USD): 14326909.388630139
Debt to equity: 0
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for JMGI.L — annual report dated 2025-06-30
Total revenue: 77132876.71232876
Net income: 67779452.05479452
Capital expenditures: 0
Operating cash flow: 21731506.84931507
Net tangible assets: 1747154794.520548
Owner earnings: 67779452.05479452
Return on net tangible assets (%): 3.8794188281064392
Buffett classification: The Gruesome
Stock price: 0.015205479452054796
P/E ratio: 0.21137540883405082
Shares outstanding: 942220167
Book value: 1747154794.520548
P/B ratio: 0.00820013740829513
Market cap (USD): 14326909.388630139
Debt to equity: 0
Effective tax rate (%): 9.625746588978796
COGS to revenue (%): 0
SG&A to revenue (%): 2.7367822828422756
Free cash flow (dilution-adjusted): 21731506.84931507
Buyback yield (%): 1022.5417510719227
Receivables turnover: 8.228408592722488
Capitalized R&D asset: 0
FCF margin (%): 28.17411689487986
Revenue growth (%): 760.4379192355697
Rule of 40 score: 788.6120361304495
Financial ratios for LPK.V — annual report dated 2021-12-31
Capital expenditures: 8849.606299212599
Depreciation & amortization: 278.74015748031496
Buffett classification: The Gruesome
Stock price: 0.39370078740157477
Shares outstanding: 22927784
Market cap (USD): 9026686.614173228
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for LPK.V — annual report dated 2022-12-31
Total revenue: 0
Operating income: -267773.5294117647
Net income: -310519.1176470588
Capital expenditures: 5387.5
Operating cash flow: -178891.91176470587
Depreciation & amortization: 0
Net tangible assets: -471494.1176470588
Owner earnings: -315906.6176470588
Buffett classification: The Gruesome
Stock price: 0.07352941176470588
Shares outstanding: 22927784
Book value: -471494.11764705874
Market cap (USD): 1685866.4705882354
Debt to equity: 0
Current ratio: 0.11340515986568413
Quick ratio: 0.11340515986568413
Free cash flow (dilution-adjusted): -241581.6176470588
Buyback yield (%): 0
Retained earnings: -50380479.4117647
Receivables turnover: 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for LPK.V — annual report dated 2023-12-31
Total revenue: 0
Operating income: -96291.66666666666
Net income: -126303.78787878787
Capital expenditures: 2032.5757575757575
Operating cash flow: -135190.15151515152
Net tangible assets: -482361.3636363636
Owner earnings: -128336.36363636363
Buffett classification: The Gruesome
Stock price: 0.05303030303030303
Shares outstanding: 22927784
Book value: -482361.36363636365
Market cap (USD): 1215867.3333333333
Debt to equity: 0
Current ratio: 0.0526147356171358
Quick ratio: 0.0526147356171358
Free cash flow (dilution-adjusted): -156968.18181818182
Buyback yield (%): 0
Retained earnings: -52033464.39393939
Receivables turnover: 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for LPK.V — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.04444444444444444
Shares outstanding: 22927784
Market cap (USD): 1019012.6222222222
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for LPK.V — quarterly report dated 2024-12-31
Total revenue: 0
Operating income: -36390.909090909096
Net income: -50839.86013986014
Capital expenditures: 922.3776223776224
Operating cash flow: -32513.986013986014
Net tangible assets: -444559.4405594406
Owner earnings: -51762.23776223776
Buffett classification: The Gruesome
Stock price: 0.04195804195804196
Shares outstanding: 22927784
Book value: -444559.4405594406
Market cap (USD): 962004.9230769231
Debt to equity: 0
Current ratio: 0.043555834202477356
Quick ratio: 0.043555834202477356
Free cash flow (dilution-adjusted): -41730.069930069934
Buyback yield (%): 0
Retained earnings: -48097386.013986014
Receivables turnover: 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for LPK.V — annual report dated 2024-12-31
Total revenue: 0
Operating income: -70190.90909090909
Net income: -66495.8041958042
Capital expenditures: 922.3776223776224
Operating cash flow: -53693.706293706295
Net tangible assets: -444559.4405594406
Owner earnings: -67418.18181818182
Buffett classification: The Gruesome
Stock price: 0.04195804195804196
Shares outstanding: 22927784
Book value: -444559.4405594406
Market cap (USD): 962004.9230769231
Debt to equity: 0
Current ratio: 0.043555834202477356
Quick ratio: 0.043555834202477356
Free cash flow (dilution-adjusted): -70158.04195804195
Buyback yield (%): 0
Retained earnings: -48097386.013986014
Receivables turnover: 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for LPK.V — quarterly report dated 2025-03-31
Total revenue: 0
Operating income: -16930.06993006993
Net income: 158078.3216783217
Capital expenditures: 0
Operating cash flow: -16448.95104895105
Net tangible assets: -281794.4055944056
Owner earnings: 158078.3216783217
Return on net tangible assets (%): -56.09704044509959
Buffett classification: The Gruesome
Stock price: 0.05594405594405595
P/E ratio: 2.0285406897528
Shares outstanding: 22927784
Book value: -281794.4055944056
Market cap (USD): 1282673.230769231
Debt to equity: 0
Current ratio: 0.01430816872331441
Quick ratio: 0.01430816872331441
Free cash flow (dilution-adjusted): -21146.853146853147
Buyback yield (%): 0
Retained earnings: -47939307.692307696
Receivables turnover: 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for LPK.V — quarterly report dated 2025-06-30
Total revenue: 0
Operating income: -10122.627737226276
Net income: -10127.737226277372
Capital expenditures: 0
Operating cash flow: -3265.693430656934
Net tangible assets: -300316.0583941606
Owner earnings: -10127.737226277372
Buffett classification: The Gruesome
Stock price: 0.058394160583941604
P/E ratio: 13.78682643150614
Shares outstanding: 22927784
Book value: -300316.0583941606
Market cap (USD): 1338848.700729927
Debt to equity: 0
Current ratio: 0.008037716509321292
Quick ratio: 0.008037716509321292
Free cash flow (dilution-adjusted): -6538.686131386861
Buyback yield (%): 0
Retained earnings: -50048967.15328467
Receivables turnover: 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for LPK.V — quarterly report dated 2025-09-30
Total revenue: 0
Operating income: -26975.539568345324
Net income: -26978.41726618705
Capital expenditures: 0
Operating cash flow: -45338.84892086331
Net tangible assets: -262307.91366906476
Owner earnings: -26978.41726618705
Buffett classification: The Gruesome
Stock price: 0.1654676258992806
P/E ratio: 54.09498340220431
Shares outstanding: 22927784
Book value: -262307.91366906476
Market cap (USD): 3793805.9856115114
Debt to equity: 0
Current ratio: 0.062102740949774964
Quick ratio: 0.062102740949774964
Free cash flow (dilution-adjusted): -47338.84892086331
Buyback yield (%): 0
Retained earnings: -49355816.54676259
Receivables turnover: 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for LPK.V — quarterly report dated 2025-12-31
Total revenue: 0
Operating income: -827495.6204379562
Net income: -827432.8467153284
Capital expenditures: 0
Operating cash flow: 80341.60583941605
Net tangible assets: -1070613.1386861312
Owner earnings: -827432.8467153284
Buffett classification: The Gruesome
Stock price: 0.19708029197080293
Shares outstanding: 22927784
Book value: -1070613.1386861315
Market cap (USD): 4518614.364963504
Debt to equity: 0
Current ratio: 0.08313823692113166
Quick ratio: 0.08313823692113166
Free cash flow (dilution-adjusted): 57199.99999999999
Buyback yield (%): 0
Retained earnings: -50903772.262773715
Receivables turnover: 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for LPK.V — annual report dated 2025-12-31
Total revenue: 0
Operating income: -882659.1240875912
Net income: -699931.3868613138
Capital expenditures: 0
Operating cash flow: 13905.839416058394
Net tangible assets: -1070613.1386861312
Owner earnings: -699931.3868613138
Buffett classification: The Gruesome
Stock price: 0.19708029197080293
Shares outstanding: 22927784
Book value: -1070613.1386861315
Market cap (USD): 4518614.364963504
Debt to equity: 0
Current ratio: 0.08313823692113166
Quick ratio: 0.08313823692113166
Free cash flow (dilution-adjusted): -19441.605839416057
Buyback yield (%): 0
Retained earnings: -50903772.262773715
Receivables turnover: 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for LX — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 2.96
Shares outstanding: 129117160
Market cap (USD): 382186793.6
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for LX — annual report dated 2022-12-31
Total revenue: 1417501580.4597702
Gross profit: 436022413.79310346
Operating income: 48052729.88505747
Net income: 118667959.77011494
Capital expenditures: 21381609.195402298
Operating cash flow: 8228879.310344827
Depreciation & amortization: 21284482.75862069
Net tangible assets: 1108776436.7816093
Owner earnings: 118570833.33333334
Return on net tangible assets (%): 10.693844980824363
Capex to operating income (%): 44.49613840160025
Buffett classification: The Good
Stock price: 1.46
P/E ratio: 1.588558983951405
Shares outstanding: 129117160
Book value: 1242636637.9310346
P/B ratio: 0.15170247508062146
Market cap (USD): 188511053.6
Debt to equity: 1.0582020455901666
Current ratio: 1.4246295661155253
Quick ratio: 1.4203099571964786
Effective tax rate (%): 19.70115762773329
Interest coverage ratio: 6.011341577395931
COGS to revenue (%): 69.24007565115528
R&D to revenue (%): 5.911931619204949
SG&A to revenue (%): 21.458033201730704
Free cash flow (dilution-adjusted): -35612500
Buyback yield (%): 24.918658291004494
Retained earnings: 703200143.6781609
Inventory turnover: 126.69649646679154
Receivables turnover: 1.382711099082973
Capitalized R&D asset: 83801724.13793103
ROCI (R&D-adjusted, %): 6.652722035944292
FCF margin (%): -2.5123428778434937
Rule of 40 score: -2.5123428778434937
Financial ratios for LX — annual report dated 2023-12-31
Total revenue: 1836439099.8593528
Gross profit: 634749648.3825598
Operating income: 264289451.47679323
Net income: 149921940.92827004
Capital expenditures: 32281715.893108297
Operating cash flow: 396282981.7158931
Depreciation & amortization: 20413783.40365682
Net tangible assets: 1239495780.5907173
Owner earnings: 138054008.43881854
Return on net tangible assets (%): 11.137916772336647
Capex to operating income (%): 12.214530588612197
Buffett classification: The Great
Stock price: 1.49
P/E ratio: 1.2832315751037813
Shares outstanding: 129117160
Book value: 1365693670.8860757
P/B ratio: 0.14086948815921432
Market cap (USD): 192384568.4
Debt to equity: 0.5676235277930712
Current ratio: 1.5013081563640582
Quick ratio: 1.4985814952002083
Effective tax rate (%): 19.659613532250113
Interest coverage ratio: 37.222391696214565
COGS to revenue (%): 65.43584546685088
R&D to revenue (%): 3.9310774030522286
SG&A to revenue (%): 16.241668697493054
Free cash flow (dilution-adjusted): 347425738.39662445
Buyback yield (%): 0
Retained earnings: 807399578.0590717
Inventory turnover: 254.2482368695135
Receivables turnover: 2.651014066914691
Capitalized R&D asset: 128338997.64780056
ROCI (R&D-adjusted, %): 17.24555968937764
Rosenberg metric: 2.371397923297699
FCF margin (%): 18.91844594374149
Revenue growth (%): 29.55464213759107
Rule of 40 score: 48.47308808133256
Financial ratios for LX — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 2.39
Shares outstanding: 129117160
Market cap (USD): 308590012.40000004
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for LX — quarterly report dated 2024-12-31
Total revenue: 501210000
Gross profit: 174526712.32876712
Operating income: 77173424.65753424
Net income: 49691643.83561644
Capital expenditures: 0
Net tangible assets: 1353032739.7260275
Owner earnings: 49691643.83561644
Return on net tangible assets (%): 3.672612079267083
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 5.09
P/E ratio: 3.30642283929108
Shares outstanding: 129117160
Book value: 1471233698.6301372
P/B ratio: 0.44670424896596883
Market cap (USD): 657206344.4
Debt to equity: 0.4904265416611499
Current ratio: 1.8646411520417676
Quick ratio: 1.8623146079067727
Effective tax rate (%): 15.717777498966074
Interest coverage ratio: 220.06484375
COGS to revenue (%): 65.17892453686736
R&D to revenue (%): 4.129212784513532
SG&A to revenue (%): 15.29443951117747
Buyback yield (%): 0
Retained earnings: 904781917.8082192
Inventory turnover: 106.72579995524725
Receivables turnover: 0.6321849526893623
Capitalized R&D asset: 20696027.397260275
ROCI (R&D-adjusted, %): 5.193254300858406
Rule of 40 score: 0
Financial ratios for LX — annual report dated 2024-12-31
Total revenue: 1945697808.2191782
Gross profit: 688524383.5616438
Operating income: 313178767.1232877
Net income: 150747945.20547944
Capital expenditures: 33843972.60273973
Operating cash flow: 148144931.50684932
Depreciation & amortization: 20299863.01369863
Net tangible assets: 1353032739.7260275
Owner earnings: 137203835.61643836
Return on net tangible assets (%): 10.140466789016536
Capex to operating income (%): 10.806598708339804
Buffett classification: The Great
Stock price: 5.09
P/E ratio: 4.359637164567545
Shares outstanding: 129117160
Book value: 1471233698.6301372
P/B ratio: 0.44670424896596883
Market cap (USD): 657206344.4
Debt to equity: 0.4904265416611499
Current ratio: 1.8646411520417676
Quick ratio: 1.8623146079067727
Effective tax rate (%): 18.70934858003967
Interest coverage ratio: 253.82535805484622
COGS to revenue (%): 64.61298457277785
R&D to revenue (%): 4.0711034122772025
SG&A to revenue (%): 15.219950668823678
Free cash flow (dilution-adjusted): 101338904.10958906
Buyback yield (%): 0
Retained earnings: 904781917.8082192
Inventory turnover: 410.71228462743346
Receivables turnover: 2.4541427282712576
Capitalized R&D asset: 155234473.28704008
ROCI (R&D-adjusted, %): 16.64618591307007
Rosenberg metric: 0.7448865873927255
FCF margin (%): 5.208357828307399
Revenue growth (%): 5.949487155233907
Rule of 40 score: 11.157844983541306
Financial ratios for LX — quarterly report dated 2025-03-31
Total revenue: 427561845.73002756
Gross profit: 167893663.91184574
Operating income: 64655785.12396695
Net income: 59273278.236914605
Capital expenditures: 0
Net tangible assets: 1426178925.6198347
Owner earnings: 59273278.236914605
Return on net tangible assets (%): 4.156089896725526
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 8.85
P/E ratio: 4.819570049056059
Shares outstanding: 129117160
Book value: 1543846556.4738293
P/B ratio: 0.7401557241607711
Market cap (USD): 1142686866
Debt to equity: 0.48047308759577473
Current ratio: 1.8526756518345289
Quick ratio: 1.8507215652414462
Effective tax rate (%): 19.031518182553704
Interest coverage ratio: 99.83007230965548
COGS to revenue (%): 60.732309117718216
R&D to revenue (%): 5.013564322529662
SG&A to revenue (%): 19.13215396802744
Buyback yield (%): 0
Retained earnings: 969040220.385675
Inventory turnover: 97.47122692725299
Receivables turnover: 0.6439195109686863
Capitalized R&D asset: 35302426.51043436
ROCI (R&D-adjusted, %): 4.030401932119261
Rosenberg metric: -0.32049862950024194
Revenue growth (%): -14.694071201686407
Rule of 40 score: -14.694071201686407
Financial ratios for LX — quarterly report dated 2025-06-30
Total revenue: 500336680.6136681
Gross profit: 177501255.23012552
Operating income: 63036122.73361228
Net income: 71325104.60251047
Capital expenditures: 0
Net tangible assets: 1500590237.0990238
Owner earnings: 71325104.60251047
Return on net tangible assets (%): 4.753136655106982
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 6.43
P/E ratio: 4.604932142455178
Shares outstanding: 129117160
Book value: 1618535425.3835428
P/B ratio: 0.5129472767661312
Market cap (USD): 830223338.8
Debt to equity: 0.4202038294344483
Current ratio: 1.8856663154916222
Quick ratio: 1.8825458346080393
Effective tax rate (%): 18.993423178543594
COGS to revenue (%): 64.52363736106287
R&D to revenue (%): 4.395366690323447
SG&A to revenue (%): 18.482254905622824
Buyback yield (%): 0
Retained earnings: 1031517294.2817295
Inventory turnover: 77.45198420665194
Receivables turnover: 0.6508602265247458
Capitalized R&D asset: 43183499.90361995
ROCI (R&D-adjusted, %): 3.4452460063063977
Rosenberg metric: 0.4481970427223674
Revenue growth (%): 17.020890804553275
Rule of 40 score: 17.020890804553275
Financial ratios for LX — quarterly report dated 2025-09-30
Total revenue: 479985674.1573034
Gross profit: 167552247.19101122
Operating income: 67018117.97752809
Net income: 73211797.75280899
Capital expenditures: 0
Net tangible assets: 1543186657.3033707
Owner earnings: 73211797.75280899
Return on net tangible assets (%): 4.744195875873005
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 4.9
P/E ratio: 2.495737793713853
Shares outstanding: 129117160
Book value: 1660752247.1910112
P/B ratio: 0.3809563317286501
Market cap (USD): 632674084
Debt to equity: 0.40223979657248865
Current ratio: 1.797860552010543
Quick ratio: 1.79580483795636
Effective tax rate (%): 19.410281424266834
Interest coverage ratio: 88.46292176492399
COGS to revenue (%): 65.09223999545867
R&D to revenue (%): 4.391019394890648
SG&A to revenue (%): 16.554215979058366
Buyback yield (%): 0
Retained earnings: 1079668679.775281
Inventory turnover: 105.77869709938183
Receivables turnover: 0.6612993829352345
Capitalized R&D asset: 42884566.44129225
ROCI (R&D-adjusted, %): 3.607829776274263
Rosenberg metric: -0.45239971867357626
Revenue growth (%): -4.067462419785808
Rule of 40 score: -4.067462419785808
Financial ratios for LX — quarterly report dated 2025-12-31
Total revenue: 434725142.85714287
Gross profit: 112011714.28571428
Operating income: 27725428.57142857
Net income: 30583428.57142857
Capital expenditures: 0
Net tangible assets: 1589166285.7142856
Owner earnings: 30583428.57142857
Return on net tangible assets (%): 1.9244951800422936
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 3
P/E ratio: 1.652568435556348
Shares outstanding: 129117160
Book value: 1707518714.2857141
P/B ratio: 0.2268505034581926
Market cap (USD): 387351480
Debt to equity: 0.40120263061747663
Current ratio: 1.8929829959822062
Quick ratio: 1.8904908354539622
Effective tax rate (%): 19.519411143315775
Interest coverage ratio: 24.21434809731753
COGS to revenue (%): 74.23390017206275
R&D to revenue (%): 4.3359745205180555
SG&A to revenue (%): 15.052433787391442
Buyback yield (%): 0
Retained earnings: 1116604857.142857
Inventory turnover: 93.66035076081099
Receivables turnover: 0.4768503777099719
Capitalized R&D asset: 40227906.83240764
ROCI (R&D-adjusted, %): 1.3187771362014515
Rosenberg metric: -2.6352171706930703
Revenue growth (%): -9.429558784149778
Rule of 40 score: -9.429558784149778
Financial ratios for LX — annual report dated 2025-12-31
Total revenue: 1878869571.4285715
Gross profit: 638378000
Operating income: 227516714.2857143
Net income: 239582428.57142857
Capital expenditures: 50417571.428571425
Operating cash flow: 516348714.28571427
Depreciation & amortization: 20524714.285714287
Net tangible assets: 1589166285.7142856
Owner earnings: 209689571.42857143
Return on net tangible assets (%): 13.194942109807084
Capex to operating income (%): 22.159941781357347
Buffett classification: The Great
Stock price: 3
P/E ratio: 1.6167775003771443
Shares outstanding: 129117160
Book value: 1707518714.2857141
P/B ratio: 0.2268505034581926
Market cap (USD): 387351480
Debt to equity: 0.40120263061747663
Current ratio: 1.8929829959822062
Quick ratio: 1.8904908354539622
Effective tax rate (%): 19.200492579746705
Interest coverage ratio: 70.06057540031674
COGS to revenue (%): 66.02329348946672
R&D to revenue (%): 4.526399498421809
SG&A to revenue (%): 17.341072941503505
Free cash flow (dilution-adjusted): 452191857.14285713
Buyback yield (%): 7.454617555242445
Retained earnings: 1116604857.142857
Inventory turnover: 360.0249181143497
Receivables turnover: 2.060933625589506
Capitalized R&D asset: 161940068.68223965
ROCI (R&D-adjusted, %): 11.192731705054195
Rosenberg metric: -0.6330705257132382
FCF margin (%): 24.067229786420967
Revenue growth (%): -3.434666807368819
Rule of 40 score: 20.632562979052146
Financial ratios for MAS — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 64.46
Shares outstanding: 201734437
Market cap (USD): 13003801809.019999
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for MAS — annual report dated 2022-12-31
Total revenue: 8680000000
Gross profit: 2713000000
Operating income: 1323000000
Net income: 905000000
Capital expenditures: 1000000
Operating cash flow: 840000000
Depreciation & amortization: 145000000
Net tangible assets: -1367000000
Owner earnings: 1049000000
Return on net tangible assets (%): -76.7373811265545
Capex to operating income (%): 0.07558578987150416
Buffett classification: The Great
Stock price: 43.77
P/E ratio: 9.756813599436466
Shares outstanding: 201734437
Book value: -242000000
Market cap (USD): 8829916307.49
Debt to equity: -14.235537190082646
Current ratio: 1.5595553202752779
Quick ratio: 0.9052408681842244
Effective tax rate (%): 24.140821458507965
Interest coverage ratio: 12.25
COGS to revenue (%): 68.7442396313364
SG&A to revenue (%): 16.129032258064516
Free cash flow (dilution-adjusted): 567000000
Buyback yield (%): 10.351173988191679
Retained earnings: -947000000
Inventory turnover: 4.827669902912621
Receivables turnover: 7.554395126196693
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 40.11522134627047
FCF margin (%): 6.532258064516129
Rule of 40 score: 6.532258064516129
Financial ratios for MAS — annual report dated 2023-12-31
Total revenue: 7967000000
Gross profit: 2836000000
Operating income: 1363000000
Net income: 960000000
Capital expenditures: 3000000
Operating cash flow: 1413000000
Depreciation & amortization: 149000000
Net tangible assets: -1106000000
Owner earnings: 1106000000
Return on net tangible assets (%): -100
Capex to operating income (%): 0.22010271460014674
Buffett classification: The Great
Stock price: 64.15
P/E ratio: 13.480483472447919
Shares outstanding: 201734437
Book value: 116000000
P/B ratio: 111.56262184094828
Market cap (USD): 12941264133.550001
Debt to equity: 28.025862068965516
Current ratio: 1.6849557522123895
Quick ratio: 1.0820058997050148
Effective tax rate (%): 22.45557350565428
Interest coverage ratio: 12.858490566037736
COGS to revenue (%): 64.40316304757123
SG&A to revenue (%): 18.589180369022216
Free cash flow (dilution-adjusted): 1139000000
Buyback yield (%): 2.72770879534754
Retained earnings: -596000000
Inventory turnover: 5.02054794520548
Receivables turnover: 7.309174311926606
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 37.159214830970555
FCF margin (%): 14.296472950922556
Revenue growth (%): -8.214285714285714
Rule of 40 score: 6.082187236636843
Financial ratios for MAS — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 81.36
Shares outstanding: 201734437
Market cap (USD): 16413113794.32
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for MAS — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 70.6
Shares outstanding: 201734437
Market cap (USD): 14242451252.199999
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for MAS — annual report dated 2024-12-31
Total revenue: 7828000000
Gross profit: 2831000000
Operating income: 1363000000
Net income: 874000000
Capital expenditures: 1000000
Operating cash flow: 1075000000
Depreciation & amortization: 150000000
Net tangible assets: -1096000000
Owner earnings: 1023000000
Return on net tangible assets (%): -93.33941605839416
Capex to operating income (%): 0.07336757153338225
Buffett classification: The Great
Stock price: 70.6
P/E ratio: 16.29571081487414
Shares outstanding: 201734437
Book value: -53000000
Market cap (USD): 14242451252.199999
Debt to equity: -60.64150943396226
Current ratio: 1.75
Quick ratio: 1.1487179487179486
Effective tax rate (%): 24.720068906115415
Interest coverage ratio: 13.767676767676768
COGS to revenue (%): 63.834951456310684
SG&A to revenue (%): 18.75319366377108
Free cash flow (dilution-adjusted): 868000000
Buyback yield (%): 5.2729687235825695
Retained earnings: -693000000
Inventory turnover: 5.3272921108742
Receivables turnover: 7.563285024154589
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 39.438657407407405
FCF margin (%): 11.088400613183444
Revenue growth (%): -1.7446968746077571
Rule of 40 score: 9.343703738575687
Financial ratios for MAS — quarterly report dated 2025-03-31
Total revenue: 1801000000
Gross profit: 644000000
Operating income: 286000000
Net income: 198000000
Capital expenditures: 32000000
Operating cash flow: -158000000
Net tangible assets: -1077000000
Owner earnings: 166000000
Return on net tangible assets (%): -15.41318477251625
Capex to operating income (%): 11.188811188811188
Buffett classification: The Great
Stock price: 67.93
P/E ratio: 17.30280341592172
Shares outstanding: 201734437
Book value: -6000000
Market cap (USD): 13703820305.410002
Debt to equity: -551
Current ratio: 1.7454772301933874
Quick ratio: 1.0923268870867124
Effective tax rate (%): 22.04724409448819
Interest coverage ratio: 11
COGS to revenue (%): 64.24208772903943
SG&A to revenue (%): 19.877845641310383
Free cash flow (dilution-adjusted): -190000000
Buyback yield (%): 0.9486405768811674
Retained earnings: -693000000
Inventory turnover: 1.1050620821394461
Receivables turnover: 1.431637519872814
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 8.162100456621005
FCF margin (%): -10.549694614103275
Rule of 40 score: -10.549694614103275
Financial ratios for MAS — quarterly report dated 2025-06-30
Total revenue: 2051000000
Gross profit: 772000000
Operating income: 411000000
Net income: 283000000
Capital expenditures: 36000000
Operating cash flow: 306000000
Net tangible assets: -925000000
Owner earnings: 247000000
Return on net tangible assets (%): -26.7027027027027
Capex to operating income (%): 8.75912408759124
Buffett classification: The Great
Stock price: 63.18
P/E ratio: 26.498090914054053
Shares outstanding: 201734437
Book value: 149000000
P/B ratio: 85.54081697758389
Market cap (USD): 12745581729.66
Debt to equity: 21.63758389261745
Current ratio: 1.8178993163455563
Quick ratio: 1.1361093847110006
Effective tax rate (%): 25.132275132275133
Interest coverage ratio: 15.807692307692308
COGS to revenue (%): 62.31106777181863
SG&A to revenue (%): 17.601170160897123
Free cash flow (dilution-adjusted): 270000000
Buyback yield (%): 0.7924314648186267
Retained earnings: -583000000
Inventory turnover: 1.1649954421148587
Receivables turnover: 1.5561456752655538
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 11.171513998369122
FCF margin (%): 13.164310092637738
Revenue growth (%): 13.881177123820098
Rule of 40 score: 27.045487216457836
Financial ratios for MAS — quarterly report dated 2025-09-30
Total revenue: 1917000000
Gross profit: 656000000
Operating income: 303000000
Net income: 200000000
Capital expenditures: 41000000
Operating cash flow: 456000000
Net tangible assets: -911000000
Owner earnings: 159000000
Return on net tangible assets (%): -17.45334796926454
Capex to operating income (%): 13.531353135313532
Buffett classification: The Great
Stock price: 69.41
P/E ratio: 20.561508476020556
Shares outstanding: 201734437
Book value: 169000000
P/B ratio: 82.85436255721893
Market cap (USD): 14002387272.17
Debt to equity: 18.775147928994084
Current ratio: 1.87753807106599
Quick ratio: 1.1992385786802031
Effective tax rate (%): 27.536231884057973
Interest coverage ratio: 12.12
COGS to revenue (%): 65.77986437141367
SG&A to revenue (%): 18.414188836724048
Free cash flow (dilution-adjusted): 415000000
Buyback yield (%): 0.8784216406045613
Retained earnings: -576000000
Inventory turnover: 1.1796071094480822
Receivables turnover: 1.6232006773920407
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 8.112449799196787
FCF margin (%): 21.648408972352634
Revenue growth (%): -6.533398342272062
Rule of 40 score: 15.115010630080572
Financial ratios for MAS — quarterly report dated 2025-12-31
Total revenue: 1793000000
Gross profit: 606000000
Operating income: 252000000
Net income: 176000000
Capital expenditures: 47000000
Operating cash flow: 418000000
Net tangible assets: -1014000000
Owner earnings: 129000000
Return on net tangible assets (%): -12.721893491124261
Capex to operating income (%): 18.650793650793652
Buffett classification: The Great
Stock price: 62.89
P/E ratio: 14.804059209953325
Shares outstanding: 201734437
Book value: 75000000
P/B ratio: 169.16104990573334
Market cap (USD): 12687078742.93
Debt to equity: 42.86666666666667
Current ratio: 1.8054672600127146
Quick ratio: 1.140495867768595
Effective tax rate (%): 22.46696035242291
Interest coverage ratio: 10.5
COGS to revenue (%): 66.20189626324596
SG&A to revenue (%): 19.743446737311768
Free cash flow (dilution-adjusted): 371000000
Buyback yield (%): 1.7104016172432555
Retained earnings: -688000000
Inventory turnover: 1.1347992351816443
Receivables turnover: 1.7441634241245136
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 6.945975744211687
FCF margin (%): 20.691578360290016
Revenue growth (%): -6.4684402712571725
Rule of 40 score: 14.223138089032844
Financial ratios for MAS — annual report dated 2025-12-31
Total revenue: 7562000000
Gross profit: 2679000000
Operating income: 1253000000
Net income: 858000000
Capital expenditures: 14000000
Operating cash flow: 1022000000
Depreciation & amortization: 148000000
Net tangible assets: -1014000000
Owner earnings: 992000000
Return on net tangible assets (%): -97.83037475345168
Capex to operating income (%): 1.1173184357541899
Buffett classification: The Great
Stock price: 62.89
P/E ratio: 14.786805061689977
Shares outstanding: 201734437
Book value: 75000000
P/B ratio: 169.16104990573334
Market cap (USD): 12687078742.93
Debt to equity: 42.86666666666667
Current ratio: 1.8054672600127146
Quick ratio: 1.140495867768595
Effective tax rate (%): 24.405286343612335
Interest coverage ratio: 12.405940594059405
COGS to revenue (%): 64.57286432160804
SG&A to revenue (%): 18.857445120338532
Free cash flow (dilution-adjusted): 836000000
Buyback yield (%): 4.500642043529488
Retained earnings: -688000000
Inventory turnover: 4.668260038240918
Receivables turnover: 7.356031128404669
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 34.53693495038589
FCF margin (%): 11.055276381909549
Revenue growth (%): -3.3980582524271843
Rule of 40 score: 7.657218129482365
Financial ratios for MCHP — annual report dated 2022-03-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 68.21
Shares outstanding: 543008370
Market cap (USD): 37038600917.7
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for MCHP — annual report dated 2023-03-31
Total revenue: 8438700000
Gross profit: 5697900000
Operating income: 3112000000
Net income: 2237700000
Capital expenditures: 486200000
Operating cash flow: 3621000000
Depreciation & amortization: 998400000
Net tangible assets: -3529000000
Owner earnings: 2749900000
Return on net tangible assets (%): -77.92292434117314
Capex to operating income (%): 15.623393316195372
Buffett classification: The Great
Stock price: 77.36
P/E ratio: 18.77245721195871
Shares outstanding: 543008370
Book value: 6513600000
P/B ratio: 6.449141412306559
Market cap (USD): 42007127503.2
Debt to equity: 0.993521247850651
Current ratio: 0.9841916244468671
Quick ratio: 0.5593535560828576
Effective tax rate (%): 23.095164449943294
Interest coverage ratio: 16.008230452674898
COGS to revenue (%): 32.47893632905542
R&D to revenue (%): 13.252041191178737
SG&A to revenue (%): 9.452877812933272
Free cash flow (dilution-adjusted): 2964400000
Buyback yield (%): 2.2515226729748457
Retained earnings: 5764100000
Inventory turnover: 2.0686844290135102
Receivables turnover: 6.464950586072168
Capitalized R&D asset: 1118300000
ROCI (R&D-adjusted, %): 26.8443516585479
FCF margin (%): 35.128633557301484
Rule of 40 score: 35.128633557301484
Financial ratios for MCHP — annual report dated 2024-03-31
Total revenue: 7634400000
Gross profit: 4995700000
Operating income: 2558700000
Net income: 1906900000
Capital expenditures: 285100000
Operating cash flow: 2892700000
Depreciation & amortization: 879500000
Net tangible assets: -2799400000
Owner earnings: 2501300000
Return on net tangible assets (%): -89.351289562049
Capex to operating income (%): 11.142376988314378
Buffett classification: The Great
Stock price: 84.57
P/E ratio: 24.0821321783523
Shares outstanding: 543008370
Book value: 6657800000
P/B ratio: 6.897506361095257
Market cap (USD): 45922217850.899994
Debt to equity: 0.9060650665384962
Current ratio: 1.1959196634119236
Quick ratio: 0.6735730729538779
Effective tax rate (%): 19.40065091508517
Interest coverage ratio: 13.396335078534031
COGS to revenue (%): 34.56329246568165
R&D to revenue (%): 14.374410562716127
SG&A to revenue (%): 9.616996751545635
Free cash flow (dilution-adjusted): 2430100000
Buyback yield (%): 2.138616220994981
Retained earnings: 6759500000
Inventory turnover: 2.0050911854103344
Receivables turnover: 6.675177056920521
Capitalized R&D asset: 1846661000
ROCI (R&D-adjusted, %): 19.193716120408016
Rosenberg metric: -0.6279173745864258
FCF margin (%): 31.83092318977261
Revenue growth (%): -9.53108891179921
Rule of 40 score: 22.299834277973396
Financial ratios for MCHP — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 76.46
Shares outstanding: 543008370
Market cap (USD): 41518419970.2
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for MCHP — quarterly report dated 2024-12-31
Capital expenditures: 0
Depreciation & amortization: 40400000
Buffett classification: The Gruesome
Stock price: 54.99
Shares outstanding: 543008370
Market cap (USD): 29860030266.3
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for MCHP — annual report dated 2025-03-31
Total revenue: 4401600000
Gross profit: 2467900000
Operating income: 375500000
Net income: -500000
Capital expenditures: 126000000
Operating cash flow: 898100000
Depreciation & amortization: 750100000
Net tangible assets: -1995500000
Owner earnings: 623600000
Capex to operating income (%): 33.55525965379494
Buffett classification: The Good
Stock price: 46.77
Shares outstanding: 543008370
Book value: 7078300000
P/B ratio: 3.587937988627213
Market cap (USD): 25396501464.9
Debt to equity: 0.8004888179365102
Current ratio: 2.589645918102329
Quick ratio: 1.4698294519954982
Effective tax rate (%): 101.2853470437018
Interest coverage ratio: 1.4936356404136835
COGS to revenue (%): 43.93175209014903
R&D to revenue (%): 22.35096328607779
SG&A to revenue (%): 14.033533260632497
Free cash flow (dilution-adjusted): 591700000
Buyback yield (%): 0.3799735964946618
Retained earnings: 5781100000
Inventory turnover: 1.4949362195593352
Receivables turnover: 6.381905176163549
Capitalized R&D asset: 2088097000
ROCI (R&D-adjusted, %): 1.7954821915209214
Rosenberg metric: -2.3034445051940953
FCF margin (%): 13.442838967648127
Revenue growth (%): -42.345174473436025
Rule of 40 score: -28.902335505787896
Financial ratios for MCHP — quarterly report dated 2025-03-31
Total revenue: 970500000
Gross profit: 501100000
Operating income: -28700000
Net income: -154600000
Capital expenditures: 14200000
Operating cash flow: 205900000
Depreciation & amortization: 187000000
Net tangible assets: -1995500000
Owner earnings: 18200000
Buffett classification: The Gruesome
Stock price: 46.77
Shares outstanding: 543008370
Book value: 7078300000
P/B ratio: 3.587937988627213
Market cap (USD): 25396501464.9
Debt to equity: 0.8004888179365102
Current ratio: 2.589645918102329
Quick ratio: 1.4698294519954982
Interest coverage ratio: -0.422680412371134
COGS to revenue (%): 48.36682122617207
R&D to revenue (%): 26.29572385368367
SG&A to revenue (%): 15.662029881504381
Free cash flow (dilution-adjusted): 151000000
Buyback yield (%): 0
Retained earnings: 5781100000
Inventory turnover: 0.3628913799768071
Receivables turnover: 1.4071335363201392
Capitalized R&D asset: 255200000
ROCI (R&D-adjusted, %): 0.9771071824171369
FCF margin (%): 15.558990211231324
Rule of 40 score: 15.558990211231324
Financial ratios for MCHP — quarterly report dated 2025-06-30
Total revenue: 1075500000
Gross profit: 576700000
Operating income: 54300000
Net income: -18600000
Capital expenditures: 17900000
Operating cash flow: 275600000
Depreciation & amortization: 171100000
Net tangible assets: -2130500000
Owner earnings: 134600000
Capex to operating income (%): 32.96500920810313
Buffett classification: The Good
Stock price: 68.51
Shares outstanding: 543008370
Book value: 6857100000
P/B ratio: 5.425253157850987
Market cap (USD): 37201503428.700005
Debt to equity: 0.8012862580391128
Current ratio: 2.313340053763441
Quick ratio: 1.3312331989247312
Interest coverage ratio: 0.9696428571428571
COGS to revenue (%): 46.37842863784286
R&D to revenue (%): 23.756392375639237
SG&A to revenue (%): 14.811715481171547
Free cash flow (dilution-adjusted): 204800000
Buyback yield (%): 0
Retained earnings: 5489200000
Inventory turnover: 0.42665298092549825
Receivables turnover: 1.4049640757674722
Capitalized R&D asset: 426484000
ROCI (R&D-adjusted, %): 0.9817863737899665
Rosenberg metric: 0.2962382445141066
FCF margin (%): 19.04230590423059
Revenue growth (%): 10.819165378670787
Rule of 40 score: 29.861471282901377
Financial ratios for MCHP — quarterly report dated 2025-09-30
Total revenue: 1140400000
Gross profit: 637900000
Operating income: 95200000
Net income: 41700000
Capital expenditures: 36500000
Operating cash flow: 88100000
Depreciation & amortization: 172700000
Net tangible assets: -2169500000
Owner earnings: 177900000
Return on net tangible assets (%): -8.200046093569947
Capex to operating income (%): 38.340336134453786
Buffett classification: The Good
Stock price: 62.96
P/E ratio: 204.96287155395686
Shares outstanding: 543008370
Book value: 6695500000
P/B ratio: 5.106087219057576
Market cap (USD): 34187806975.2
Debt to equity: 0.8084086326637294
Current ratio: 2.251676566392029
Quick ratio: 1.2023376125694578
Effective tax rate (%): -31.132075471698112
Interest coverage ratio: 1.730909090909091
COGS to revenue (%): 44.06348649596632
R&D to revenue (%): 23.00070150824272
SG&A to revenue (%): 15.108733777621888
Free cash flow (dilution-adjusted): -10000000
Buyback yield (%): 0
Retained earnings: 5257300000
Inventory turnover: 0.4587784168720898
Receivables turnover: 1.5282766014473332
Capitalized R&D asset: 517701000
ROCI (R&D-adjusted, %): 0.7159795617597875
Rosenberg metric: 0.23953033268101762
FCF margin (%): -0.8768853034023149
Revenue growth (%): 6.0344026034402605
Rule of 40 score: 5.157517300037946
Financial ratios for MCHP — quarterly report dated 2025-12-31
Total revenue: 1186000000
Gross profit: 706900000
Operating income: 156500000
Net income: 62700000
Capital expenditures: 22500000
Operating cash flow: 341400000
Depreciation & amortization: 171800000
Net tangible assets: -2234200000
Owner earnings: 212000000
Return on net tangible assets (%): -9.488855071166412
Capex to operating income (%): 14.376996805111823
Buffett classification: The Great
Stock price: 63.03
P/E ratio: 136.46657719736842
Shares outstanding: 543008370
Book value: 6560400000
P/B ratio: 5.217032126257545
Market cap (USD): 34225817561.100002
Debt to equity: 0.8238217181879154
Current ratio: 2.1623713773246482
Quick ratio: 1.1638818087416218
Effective tax rate (%): 33.01282051282051
Interest coverage ratio: 2.8663003663003663
COGS to revenue (%): 40.39629005059022
R&D to revenue (%): 23.128161888701516
SG&A to revenue (%): 14.207419898819563
Free cash flow (dilution-adjusted): 246300000
Buyback yield (%): 0
Retained earnings: 5046100000
Inventory turnover: 0.45296397844379316
Receivables turnover: 1.6219912472647702
Capitalized R&D asset: 534356000
ROCI (R&D-adjusted, %): 1.2084054198009606
Rosenberg metric: 0.2630575676706062
FCF margin (%): 20.767284991568296
Revenue growth (%): 3.998596983514556
Rule of 40 score: 24.765881975082852
Financial ratios for MEDCL.PA — annual report dated 2022-03-31
Total revenue: 4544444.444444444
Gross profit: 4544444.444444444
Operating income: -26462222.22222222
Net income: -27562222.22222222
Capital expenditures: 1785555.5555555555
Operating cash flow: -23735555.555555556
Depreciation & amortization: 1684444.4444444445
Net tangible assets: -16707777.777777778
Owner earnings: -27663333.333333332
Buffett classification: The Gruesome
Stock price: 8.244444444444444
Shares outstanding: 35909370
Book value: -14856666.666666672
Market cap (USD): 296052805.99999994
Debt to equity: -3.5518659786104245
Current ratio: 0.8910331842786539
Quick ratio: 0.8910331842786539
Interest coverage ratio: -12.915401301518438
COGS to revenue (%): 0
R&D to revenue (%): 577.1882640586798
SG&A to revenue (%): 17.897310513447433
Free cash flow (dilution-adjusted): -28588888.888888888
Buyback yield (%): 0.07205921680517136
Retained earnings: -27562222.22222222
Receivables turnover: 5.118898623279098
Capitalized R&D asset: 26230000
ROCI (R&D-adjusted, %): -27.227072028042738
FCF margin (%): -629.0953545232275
Rule of 40 score: -629.0953545232275
Financial ratios for MEDCL.PA — annual report dated 2023-03-31
Total revenue: 10808695.652173912
Gross profit: 10808695.652173912
Operating income: -26135869.56521739
Net income: -34793478.26086956
Capital expenditures: 573913.0434782609
Operating cash flow: -22831521.739130434
Depreciation & amortization: 1809782.608695652
Net tangible assets: -48065217.391304344
Owner earnings: -33557608.69565217
Buffett classification: The Gruesome
Stock price: 10.66304347826087
Shares outstanding: 35909370
Book value: -45971739.13043478
Market cap (USD): 382903173.5869565
Debt to equity: -1.292216390031683
Current ratio: 0.3431477422183253
Quick ratio: 0.3431477422183253
Interest coverage ratio: -6.115208545269583
COGS to revenue (%): 0
R&D to revenue (%): 280.8226065969429
SG&A to revenue (%): 6.325422365245374
Free cash flow (dilution-adjusted): -26424999.999999996
Buyback yield (%): 0
Retained earnings: -34793478.26086956
Receivables turnover: 4.751075011944577
Capitalized R&D asset: 47927360.86956522
ROCI (R&D-adjusted, %): -82.11165214821908
Rosenberg metric: 0.2388200994178219
FCF margin (%): -244.4790828640386
Revenue growth (%): 137.84415860529393
Rule of 40 score: -106.63492425874466
Financial ratios for MEDCL.PA — annual report dated 2024-03-31
Total revenue: 9849462.365591398
Gross profit: 9849462.365591398
Operating income: -22553763.440860216
Net income: -26922580.64516129
Capital expenditures: 347311.82795698923
Operating cash flow: -12819354.838709677
Depreciation & amortization: 1848387.0967741935
Net tangible assets: -46532258.06451613
Owner earnings: -25421505.376344085
Buffett classification: The Gruesome
Stock price: 10.42391304347826
Shares outstanding: 35909370
Book value: -43896774.19354839
Market cap (USD): 374316150.32608694
Debt to equity: -1.444272976680384
Current ratio: 1.6554111502489979
Quick ratio: 1.6554111502489979
Interest coverage ratio: -4.542993285683345
COGS to revenue (%): 0
R&D to revenue (%): 230.08733624454146
SG&A to revenue (%): 6.080786026200874
Free cash flow (dilution-adjusted): -17120430.107526883
Buyback yield (%): 0.007181555058922627
Retained earnings: -26922580.64516129
Receivables turnover: 6.21438263229308
Capitalized R&D asset: 51654950.37400654
ROCI (R&D-adjusted, %): -35.704538936254664
Rosenberg metric: -0.03160231418642483
FCF margin (%): -173.82096069869
Revenue growth (%): -8.874644244327369
Rule of 40 score: -182.69560494301734
Financial ratios for MEDCL.PA — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: -62941111.11111111
Buffett classification: The Gruesome
Stock price: 17.42222222222222
Shares outstanding: 35909370
Book value: -60033333.33333333
Market cap (USD): 625621024
Debt to equity: -1.1031834166203962
Current ratio: 1.4622286186728726
Quick ratio: 1.4622286186728726
Buyback yield (%): 0
Retained earnings: -16186666.666666666
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for MEDCL.PA — quarterly report dated 2025-03-31
Capital expenditures: 0
Net tangible assets: -20667391.304347824
Buffett classification: The Gruesome
Stock price: 15.652173913043478
Shares outstanding: 35909370
Book value: -17790217.391304344
Market cap (USD): 562059704.3478261
Debt to equity: -3.589906519215495
Current ratio: 2.6985673160607884
Quick ratio: 2.6985673160607884
Buyback yield (%): 0
Retained earnings: -20041304.347826086
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for MEDCL.PA — annual report dated 2025-03-31
Total revenue: 27761956.52173913
Gross profit: 27761956.52173913
Operating income: -11782608.695652174
Net income: -20041304.347826086
Capital expenditures: 811956.5217391304
Operating cash flow: 21157608.695652172
Depreciation & amortization: 2163043.4782608696
Net tangible assets: -20667391.304347824
Owner earnings: -18690217.391304344
Buffett classification: The Gruesome
Stock price: 15.652173913043478
Shares outstanding: 35909370
Book value: -17790217.391304344
Market cap (USD): 562059704.3478261
Debt to equity: -3.589906519215495
Current ratio: 2.6985673160607884
Quick ratio: 2.6985673160607884
Interest coverage ratio: -2.1305031446540883
COGS to revenue (%): 0
R&D to revenue (%): 95.19204416428487
SG&A to revenue (%): 2.071179671900082
Free cash flow (dilution-adjusted): 16133695.65217391
Buyback yield (%): 0
Retained earnings: -20041304.347826086
Receivables turnover: 18.02470007057163
Capitalized R&D asset: 51627534.94623656
ROCI (R&D-adjusted, %): -10.075804130950186
Rosenberg metric: 0.7904070774918103
FCF margin (%): 58.114404291139735
Revenue growth (%): 181.86265900892352
Rule of 40 score: 239.97706330006326
Financial ratios for MLO.V — annual report dated 2021-10-31
Capital expenditures: 841242.2764227643
Buffett classification: The Gruesome
Stock price: 1.5853658536585367
Shares outstanding: 30838500
Market cap (USD): 48890304.878048785
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for MLO.V — annual report dated 2022-10-31
Total revenue: 0
Gross profit: 0
Operating income: -445397.79411764705
Net income: -4383408.823529411
Capital expenditures: 6811.029411764705
Operating cash flow: -275911.0294117647
Depreciation & amortization: 0
Net tangible assets: -573186.7647058823
Owner earnings: -4390219.852941176
Buffett classification: The Gruesome
Stock price: 0.2205882352941176
Shares outstanding: 30838500
Book value: -573186.7647058823
Market cap (USD): 6802610.294117646
Debt to equity: -0.19840956263613904
Current ratio: 0.04126190750848476
Quick ratio: 0.04126190750848476
Interest coverage ratio: -11013.472727272729
Free cash flow (dilution-adjusted): -287133.82352941175
Buyback yield (%): 0
Retained earnings: -5457905.147058823
Receivables turnover: 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for MLO.V — annual report dated 2023-10-31
Total revenue: 0
Gross profit: -25886.956521739132
Operating income: -305945.6521739131
Net income: -428184.7826086957
Capital expenditures: 52446.37681159421
Operating cash flow: -452113.7681159421
Depreciation & amortization: 25886.956521739132
Net tangible assets: -570717.3913043479
Owner earnings: -454744.2028985508
Buffett classification: The Gruesome
Stock price: 0.05072463768115943
Shares outstanding: 30838500
Book value: -409626.81159420294
Market cap (USD): 1564271.739130435
Debt to equity: -0.29733320360526105
Current ratio: 0.0286682907488315
Quick ratio: 0.0286682907488315
Interest coverage ratio: -45.11219147344802
Free cash flow (dilution-adjusted): -452113.7681159421
Buyback yield (%): 0
Retained earnings: -5806989.855072464
Receivables turnover: 0
Capitalized R&D asset: 0
Rule of 40 score: 0